{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:57:19Z","timestamp":1788976639199,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.berh.2022.101763","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:23:44Z","timestamp":1656375824000},"page":"101763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Muscle biopsy in myositis: What the rheumatologist needs to know"],"prefix":"10.1016","volume":"36","author":[{"given":"Ashirwad","family":"Merve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2022.101763_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"10.1016\/j.berh.2022.101763_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2022.101763_bib3","article-title":"Immune-mediated necrotizing myopathies working G. 224th ENMC international workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies zandvoort, The Netherlands, 14-16 october 2016","author":"Allenbach","year":"2017","journal-title":"Neuromuscular disorders : NMD"},{"key":"10.1016\/j.berh.2022.101763_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in inflammatory myopathies-an expanded definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004552","article-title":"A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis","volume":"4","author":"Brady","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/nan.12519","article-title":"Diagnostic potential of sarcoplasmic MxA expression in subsets of dermatomyositis","volume":"45","author":"Uruha","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"10.1016\/j.berh.2022.101763_bib8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3899\/jrheum.141443","article-title":"The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis","volume":"42","author":"Pinal-Fernandez","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13317-014-0062-2","article-title":"Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis","volume":"5","author":"Vattemi","year":"2014","journal-title":"Auto Immun Highlights"},{"issue":"6","key":"10.1016\/j.berh.2022.101763_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2019.03.002","article-title":"1st ENMC European meeting: the EURO-NMD pathology working group recommended standards for muscle pathology amsterdam, The Netherlands","volume":"29","author":"Udd","year":"2019","journal-title":"Neuromuscul Disord : NMD"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/practneurol-2019-002465","article-title":"Muscle biopsy: what and why and when?","volume":"20","author":"Walters","year":"2020","journal-title":"Practical Neurol"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5414\/NP300740","article-title":"Clinical Neuropathology practice guide 3-2014: combined nerve and muscle biopsy in the diagnostic workup of neuropathy - the Bordeaux experience","volume":"33","author":"Vital","year":"2014","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.berh.2022.101763_bib13","series-title":"Corticosteroid induced myopathy","author":"Surmachevska","year":"2022"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl 11","key":"10.1016\/j.berh.2022.101763_bib15","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101763_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1744666X.2019.1699059","article-title":"Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis","volume":"16","author":"Gono","year":"2020","journal-title":"Expet Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.semarthrit.2020.11.001","article-title":"Conventional ultrasound and elastography as imaging outcome tools in autoimmune myositis: a systematic review by the OMERACT ultrasound group","volume":"51","author":"Paramalingam","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12955","article-title":"The role of interferons type I, II and III in myositis: a review","volume":"31","author":"Bolko","year":"2021","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.berh.2022.101763_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e3282efdc66","article-title":"Skeletal muscle imaging and inflammatory myopathies","volume":"19","author":"Kuo","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1017\/S1431927621011958","article-title":"Preparation of samples for large-scale Automated electron microscopy of tissue and cell ultrastructure","volume":"27","author":"Dittmayer","year":"2021","journal-title":"Microsc Microanal"},{"issue":"1","key":"10.1016\/j.berh.2022.101763_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-022-01320-z","article-title":"The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies","volume":"10","author":"Becker","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib22","first-page":"739","article-title":"Juvenile idiopathic inflammatory myopathies","volume":"65","author":"Huber","year":"2018","journal-title":"Pediatr Clin"},{"issue":"10","key":"10.1016\/j.berh.2022.101763_bib23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.nmd.2021.08.007","article-title":"Inflammatory myopathies in childhood","volume":"31","author":"Stenzel","year":"2021","journal-title":"Neuromuscul Disord : NMD"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/nan.12528","article-title":"Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features","volume":"45","author":"Yasin","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.berh.2022.101763_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-020-01007-3","article-title":"Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups","volume":"8","author":"Nguyen","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"1\u20133","key":"10.1016\/j.berh.2022.101763_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0022-510X(89)90228-1","article-title":"Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle","volume":"94","author":"De Visser","year":"1989","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.berh.2022.101763_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","article-title":"Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease","volume":"74","author":"Varsani","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2022.101763_bib28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2022.101763_bib29","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2022.101763_bib30","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1212\/WNL.0000000000006124","article-title":"Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer","volume":"91","author":"Touat","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.berh.2022.101763_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093054","article-title":"Immune checkpoint inhibitor-related myositis: from biology to bedside","volume":"21","author":"Solimando","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"25","key":"10.1016\/j.berh.2022.101763_bib32","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2022.101763_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fneur.2019.00553","article-title":"Colchicine myopathy: a case series including muscle MRI and ABCB1 polymorphism data","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Neurol"},{"issue":"24","key":"10.1016\/j.berh.2022.101763_bib34","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMc2031085","article-title":"Covid-19-Associated myopathy caused by type I interferonopathy","volume":"383","author":"Manzano","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.berh.2022.101763_bib35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jamaneurol.2021.2004","article-title":"Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died","volume":"78","author":"Aschman","year":"2021","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"issue":"10260","key":"10.1016\/j.berh.2022.101763_bib37","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S0140-6736(20)32079-1","article-title":"Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral","volume":"396","author":"Dittmayer","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ana.26318","article-title":"COVID-19-associated critical illness myopathy with direct viral effects","volume":"91","author":"Dodig","year":"2022","journal-title":"Ann Neurol"},{"issue":"9856","key":"10.1016\/j.berh.2022.101763_bib39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0140-6736(12)60683-7","article-title":"A tiger man","volume":"380","author":"Wieers","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnen\/62.5.464","article-title":"Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis","volume":"62","author":"Bassez","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4\u20135","key":"10.1016\/j.berh.2022.101763_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.autrev.2014.01.018","article-title":"Eosinophilic myositis: an updated review","volume":"13","author":"Selva-O'Callaghan","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview","volume":"31","author":"Eleftheriou","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"24","key":"10.1016\/j.berh.2022.101763_bib43","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2169\/internalmedicine.53.2871","article-title":"Protracted febrile myalgia syndrome in a Japanese patient with fasciitis detected on MRI","volume":"53","author":"Fujikawa","year":"2014","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00401-010-0727-5","article-title":"Muscular dystrophies: an update on pathology and diagnosis","volume":"120","author":"Sewry","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/dmcn.14365","article-title":"Congenital myopathies: an update","volume":"62","author":"Claeys","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.berh.2022.101763_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.spen.2019.01.008","article-title":"Recently identified congenital myopathies","volume":"29","author":"Radke","year":"2019","journal-title":"Semin Pediatr Neurol"},{"issue":"7","key":"10.1016\/j.berh.2022.101763_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6070064","article-title":"Myopathology of adult and paediatric mitochondrial diseases","volume":"6","author":"Phadke","year":"2017","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12950","article-title":"Infective myositis","volume":"31","author":"Narayanappa","year":"2021","journal-title":"Brain Pathol"},{"issue":"11","key":"10.1016\/j.berh.2022.101763_bib49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5858\/arpa.2017-0496-CP","article-title":"US Food and drug administration approval of whole slide imaging for primary diagnosis: a key milestone is reached and new questions are raised","volume":"142","author":"Evans","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.berh.2022.101763_bib50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jclinpath-2017-204808","article-title":"Digital pathology access and usage in the UK: results from a national survey on behalf of the National Cancer Research Institute's CM-Path initiative","volume":"71","author":"Williams","year":"2018","journal-title":"J Clin Pathol"},{"issue":"11","key":"10.1016\/j.berh.2022.101763_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113697","article-title":"Digital pathology: advantages, limitations and emerging perspectives","volume":"9","author":"Jahn","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.berh.2022.101763_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5858\/arpa.2017-0536-OA","article-title":"Validation of a muscle-specific tissue image analysis tool for quantitative assessment of dystrophin staining in frozen muscle biopsies","volume":"143","author":"Aeffner","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.berh.2022.101763_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00247-016-3777-6","article-title":"Muscle MRI in pediatrics: clinical, pathological and genetic correlation","volume":"47","author":"Cejas","year":"2017","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.berh.2022.101763_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.41944","article-title":"Long-term extension study of tofacitinib in refractory dermatomyositis","volume":"74","author":"Paik","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2022.101763_bib56","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.berh.2022.101763_bib57","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/nan.12498","article-title":"Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis","volume":"45","author":"Soponkanaporn","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.berh.2022.101763_bib58","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1002\/mus.27003","article-title":"COVID-19-associated myositis with severe proximal and bulbar weakness","volume":"62","author":"Zhang","year":"2020","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.berh.2022.101763_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.rdc.2011.01.010","article-title":"Essential muscle pathology for the rheumatologist","volume":"37","author":"Harris","year":"2011","journal-title":"Rheum Dis Clin N Am"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:27Z","timestamp":1761499347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1521694222000225"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101763","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle biopsy in myositis: What the rheumatologist needs to know","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101763"}}